Chordoma is a rare midline malignant tumor arising from embryonic remnants of the primitive notochord. The base of the skull is the second most common site of disease after the sacrococcygeal region. Intracranial chordoma constitutes about 30-35% of chordoma cases. Metastasis from chordoma is uncommon but if occurs, it tends to spread to the lungs. Cerebrospinal fluid seeding or drop metastasis is very rare. Here we describe a case of a clival chordoma with drop metastases.
CASE REPORT
A 59-year-old Chinese lady presented with 2 weeks history of blurred vision. She described a "curtain" obscuring her vision which started in the left eye followed two days later in the right eye. Ophthalmic evaluation revealed bitemporal inferior quadrantanopia.
A magnetic resonance imaging (MRI) of the brain found a lobulated mass in the sellar and suprasellar regions measuring 1.9 x 2.1 x 3.8 cm (anteroposterior x transverse x craniocaudal dimensions) ( fig. 1 ). The mass showed intermediate signal intensity on T1-weighted images and high signal intensity on T2-weighted images. There was homogenous enhancement of the mass on post contrast images. Susceptibility artefacts within the mass were indicative of hemorrhagic foci or calcifications. The optic chiasm was displaced posterolaterally due to mass effect. The mass was closely related to the cavernous sinuses with no evidence of tumor invasion. Areas of abnormal marrow signal with contrast enhancement were noted in the dorsum sellae and clivus on the MRI. Computed tomography (CT) showed a hyperdense sellar/suprasellar mass with irregularity of the dorsum sella turcica and thinning of the sellar floor suggesting erosion ( fig. 2 ). The mass was presumed to be a pituitary macroadenoma, as the normal pituitary gland was not visualized on MRI.
Biochemical tests revealed monomeric hyperprolactinemia, hypocortisolism, hypothyroidism and central diabetes insipidus.A follow-up MRI done a month later showed mild enlargement of the mass, measuring 2.3 x 2.4 x 4.2 cm, with compression of the third ventricle and foramen of Monro ( fig. 3 ). This resulted in acute obstructive hydrocephalus with transependymal cerebrospinal fluid seepage.
The patient thus underwent transphenoidal resection of the mass. Intraoperatively, a well demarcated soft tissue mass was found compressing and flattening the normal pituitary gland anteroinferiorly. The mass was seen spilling into the anterior half of the third ventricle. Gross total resection of the mass was achieved. The Liliequist membrane was intact.
Histopathology demonstrated cellular tissue with cords and nests of physaliferous cells separated by fibrous septa with extensive myxoid stroma ( fig. 4) . Areas of necrosis were present. No mitotic figures were seen. The tumor cells stained positively with Vimentin, keratins and EMA but stained negatively with synaptophysin. Immunohistochemistry for brachyury to identify notochord differentiation was positive, compatible with chordoma.
indenting the medulla oblongata on a surveillance MRI ( fig.  5 ). This lesion showed similar signal characteristics as the index tumor with intermediate signal intensity on T1-weighted images and high signal intensity on T2-weighted images and was deemed to be a drop metastasis. MRI whole spine which was performed to look for other drop metastases found another similar appearing nodular lesion in the posterior epidural space at the L4-5 level ( fig. 6 ), also suspicious for metastasis. The patient was asymptomatic from the metastases and decision was made for expectant management following discussion in a multidisciplinary tumor board and consultation with the patient. 
Etiology

Clinical & Imaging Findings:
The clinical presentation for patients with intracranial chordomas is dependent on the location of the tumors and occurs in an insidious manner due to the slow-growing nature of the tumor. Generally, they tend to cause diplopia and headache. Abducens nerve tends to be more commonly affected than other cranial nerves. Headaches are usually in the retro-orbital and occipital regions. One may also present with sinonasal congestion if the tumor extends inferiorly into the paranasal sinuses, nasal meati or nasopharynx. Tumors occurring in the sella may compress the pituitary glands and infundibulum, resulting in pituitary dysfunction such as in our case [1, 2].
The classic appearance of intracranial chordoma on CT is that of a centrally located, well-circumscribed, expansile softtissue mass that arises from the clivus with associated extensive lytic bone destruction. Chordomas are usually hyperdense to the brain parenchyma on CT [1].
On MRI, chordomas show intermediate to low signal intensity on T1-weighted images [1] . Small foci of T1-weighted hyperintensity can sometimes be visualized in the tumor, representing intratumoral hemorrhage or a mucus pool. Presence of hemorrhage can be confirmed by blooming artefacts on gradient echo images. Classic intracranial chordoma demonstrates high signal intensity on T2-weighted images due to high water content. Contrast enhancement is variable -majority of chordomas show moderate to marked enhancement, however necrotic tumors may have slight or even absent enhancement [1] . Chordomas typically demonstrate calcifications which explain the heterogeneity of these lesions [1, 2] . Calcifications are more frequently found in the mucinous subtypes and are thought to represent bone fragments from adjacent osseous destruction rather than dystrophic calcifications [1]. These are seen as foci of low signal on T1-weighted and T2-weighted images or abnormal susceptibility artefact on T2* weighted images within the mass on MRI.
MRI is superior to CT for evaluation of chordomas due to excellent soft tissue contrast and multiplanar capabilities. Sagittal images are particularly useful in defining the posterior margin of the tumor, depicting the relation between the tumor and brainstem as well as nasopharyngeal extension of the tumor. Sagittal imaging is also valuable in disclosing transdural transgression, an important factor in surgical planning. The only area in which CT is better than MRI is in evaluation of bony destruction and calcifications [1] .
The literature on the evaluation of chordomas using PET imaging is scant and limited to a few case reports that showed chordomas demonstrating hypermetabolism on 18F-FDG PET/CT [6] [7] [8] .
Treatment & Prognosis:
Chordoma grows slowly but is locally aggressive and associated with high recurrence rate. While it is rarely metastatic, metastases are most commonly to the lungs and in younger patients. Patients with bone metastases have the worst prognosis due to more rapid progression of the disease [4, 9] . Other sites of distant metastasis include the liver, lymph nodes and cerebrospinal fluid seeding. A case of cutaneous metastasis has also been described in the literature [4, [9] [10] [11] [12] . Cerebrospinal fluid seeding or drop metastasis is rare because intracranial chordomas are uncommon and they tend to originate at the clivus which is extradural in location [10] [11] [12] [13] [14] . Very few cases of spinal dissemination of clival chordoma have been described in the literature [12] . The slow growth rate of chordoma and late age of onset may be masking the true incidence of intradural drop metastases [9] . In addition, a few reported cases of drop metastases were asymptomatic like our case; some cases were discovered only during postmortem examination. Clinically, patients may present with symptoms of lumbago, cauda equina syndrome, paraparesis or sensory disturbances [9, 12] .
Dissemination of tumor cells may be caused by the tumor transgressing the dura mater, although tumor spread may also result from surgical intervention [12, 14] . In our case, drop metastases are most likely due to the primary tumor location centered within the dura and disruption of the dura during the surgery.
The metastatic lesions typically have similar imaging appearance to the primary tumor. The bones may be secondarily involved, with scalloping and erosion by the extramedullary lesions [12] . A case report by Uggowitzer et al described drop metastases from a chondroid chordoma which had a dumbbell appearance, mimicking neurogenic tumors [14] . In another case reported by Martin et al, drop metastasis was complicated by an intradural hematoma [9] .
Overall median survival time is approximately 6 years with a survival rate of 63-70% at 5 years, falling to 16-51% at 10 years. Prognosis was reported as more favorable in the chondroid subtypes which often feature low grade behavior DISCUSSION compared to the dedifferentiated subtypes which show more aggressive clinical course and features of high grade spindle cell sarcoma [3, 13, 15, 16] . However, Jian BJ et al., in their systematic review of 560 patients who had received treatment for intracranial chordomas, found no significant difference between the prognoses of treated intracranial chondroid chordomas from typical chordomas [16] . Patients with craniocervical lesions show worse prognosis compared to those presenting with lumbosacral lesions [17] .
En-bloc surgical resection is the principal treatment for chordomas, even those that involve the cervical spine. There is more favorable prognosis if negative margin is achieved. Aggressive surgical resection shows less than 50% local recurrence rate compared to almost 100% in those with radiotherapy alone or subtotal resections. Surgery can be performed via minimally invasive techniques, e.g. transphenoidal resection or craniotomy. The former may result in inadequate margins due to technical difficulties in clearing the whole tumor [13, 15, 17, 18] .
Adjuvant radiotherapy may also be employed to help achieve better long-term outcome particularly in patients with subtotal resections [13, 15, 17, 18] . Radiation doses of more than 60 Gy are usually required to achieve satisfactory treatment. This dosage exceeds the tolerance level of the neurologic structures, particularly the brain stem and optic pathway. Patients undergoing high dose proton radiation have been reported to experience less side effects and can be used in combination with photon therapy [13, 19] . However, a systematic review of 560 patients by Jian BJ et al. showed no significant difference between patients who had surgical resections alone to those coupled with adjuvant radiotherapy [16] .
Chordomas, as many other low-grade tumors, are not sensitive to chemotherapy. Thus, the mainstay of the treatment of chordomas lies in achieving negative surgical margins with aggressive primary tumor resection that may be coupled with adjuvant radiotherapy [13, 17] . Characteristic ring and arc calcifications denoting chondroid matrix will be helpful if present. This heterogeneously enhancing mass may also show more restricted diffusion or higher ADC value than chordoma [27]. 6. Ecchordosis physalifora: A benign intradural ectopic notochord remnant mostly found in the prepontine cistern with a stalk attached to the clivus. CT is not ideal for imaging of the posterior fossa due to streak artefacts from the skull base. It is a rare incidental finding on MRI that typically demonstrates T1-weighted hypointensity and T2-weighted hyperintensity. This lesion is considered along the same spectrum as the more aggressive chordoma [28, 29] .
Intracranial chordomas are rare but internal calcifications, erosion and marrow involvement of the underlying bones, particularly the clivus, should direct us towards chordoma as a diagnosis. MRI spine should be considered to screen for drop metastases particularly if the primary tumor is located within the dura or has breached the dura. The nodule is isointense on T1W sequence and (c) demonstrates homogenous contrast enhancement. This was also deemed to be a metastasis as the dura had been breached during the transphenoidal surgery. 
Findings on imaging
Usually, an intracranial chordoma presents as a midline heterogenous soft tissue mass with internal calcifications due to adjacent bone destruction. Most of the time, it involves the clivus. It is hyperdense to brain parenchyma on CT. Intermediate-low T1 signal and high T2 signal are expected on MRI. Blooming artefact on T2* sequence on gradient-echo MRI may be seen, representing haemorrhage or calcifications from the eroded bony fragments. Variable enhancement is seen following intravenous contrast administration. FDG avid on PET. 
